---
figid: PMC8310245__viruses-13-01307-g003
figtitle: Antivirals against the Chikungunya Virus
organisms:
- Chikungunya virus
- Influenza A virus
- Dengue virus
- Respiratory syncytial virus
- Orthomyxoviridae
- Zika virus
- West Nile virus
- DNA viruses
- Japanese encephalitis virus
- Sindbis virus
- Reovirus sp.
- Ebola virus sp.
- Semliki Forest virus
- ssRNA viruses
- Venezuelan equine encephalitis virus
- Dengue virus group
- Ross River virus
- Mayaro virus
- Aura virus
- Gallus gallus
- Danio rerio
- Aedes aegypti
- Aedes albopictus
- Homo sapiens
- Mus musculus
- unidentified
- NA
- NA
organisms_ner:
- Drosophila melanogaster
pmcid: PMC8310245
filename: viruses-13-01307-g003.jpg
figlink: /pmc/articles/PMC8310245/figure/viruses-13-01307-f003/
number: F3
caption: 'Chemical structure of selected host-targeting compounds. Inhibitor of the
  viral entry and membrane fusion: chloroquine, hydroxychloroquine, obatoclax, niclosamide,
  nitazoxanide, and 5-(N-ethyl-N-isopropyl)amiloride. Inhibitor of the lipid pathway:
  orlistat, cerulenin, CAY10566, tivozanib, pimozide, 5-tetradecyloxy-2-furoic acid,
  imipramine, U18999A, and LXR-623. Inhibitor of the pyrimidine and purine synthesis:
  ribavirin, merimepodip, mycophenolic acid, 6-azauridine, DD264, antimycin A1a, RYL-634,
  and atovaquone.'
papertitle: Antivirals against the Chikungunya Virus.
reftext: Verena Battisti, et al. Viruses. 2021 Jul;13(7):1307.
year: '2021'
doi: 10.3390/v13071307
journal_title: Viruses
journal_nlm_ta: Viruses
publisher_name: MDPI
keywords: Chikungunya virus | alphavirus | antiviral therapy | direct-acting antivirals
  | host-directed antivirals | in silico screening | in vivo validation | antiviral
  drug development
automl_pathway: 0.6529648
figid_alias: PMC8310245__F3
figtype: Figure
redirect_from: /figures/PMC8310245__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8310245__viruses-13-01307-g003.html
  '@type': Dataset
  description: 'Chemical structure of selected host-targeting compounds. Inhibitor
    of the viral entry and membrane fusion: chloroquine, hydroxychloroquine, obatoclax,
    niclosamide, nitazoxanide, and 5-(N-ethyl-N-isopropyl)amiloride. Inhibitor of
    the lipid pathway: orlistat, cerulenin, CAY10566, tivozanib, pimozide, 5-tetradecyloxy-2-furoic
    acid, imipramine, U18999A, and LXR-623. Inhibitor of the pyrimidine and purine
    synthesis: ribavirin, merimepodip, mycophenolic acid, 6-azauridine, DD264, antimycin
    A1a, RYL-634, and atovaquone.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - rh
  - roh
  - mo
  - Pos
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - an
  - fo
  - homer
  - lncRNA:iab8
---
